Interestingly, compared to the control group, S100A9 dimer pretreatment enhances the anti‐inflammatory effect of human amniotic mesenchymal stem cells at days 7, 14, and 28 post‐MI, facilitating the recovery of cardiac function.50 This evidence concerns the gene S100A9 and myocardial infarction.